Expensive drug medication to curb by HIRA

The government's NHI financial stabilization policy restricted expensive drug prescription, which triggered a serious concern to foreign multinational drug manufacturers who are currently producing most of expensive original drugs.

The HIRA (the Health Insurance Review Agency) revised the insurance reimbursement guideline covering that by taking effects from June 1 this year, expensive COX-...